Factane

Factane is a human coagulation factor VIII used to manage bleeding episodes in patients with hemophilia A. This intravenous medication helps replace missing clotting factors to promote blood coagulation.

Factane is primarily used to control and prevent bleeding in individuals with hemophilia A, a condition characterized by a deficiency in factor VIII. It is administered intravenously to help the blood clot properly, reducing the risk of excessive bleeding during surgeries or injuries. Factane is also used for routine prophylaxis to prevent bleeding episodes in patients with severe hemophilia A.

Common effects of Factane may include mild reactions at the injection site, such as redness or swelling. Some users might experience headaches, nausea, or dizziness. These effects are generally mild and temporary. Severe allergic reactions are rare but require immediate medical attention.

Factane should be used under medical supervision. Patients with a history of allergic reactions to factor VIII products should exercise caution. It is important to store Factane properly to maintain its effectiveness. Always follow the healthcare provider's instructions for administration and monitoring.

Factane may interact with certain medications, including those that affect blood clotting. It is important to inform your healthcare provider about all medications you are taking. Alcohol and other substances that affect blood clotting should be avoided unless approved by a medical professional.